Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 3
2005 5
2006 14
2007 9
2008 3
2009 15
2010 12
2011 15
2012 10
2013 10
2014 12
2015 15
2016 13
2017 22
2018 19
2019 24
2020 28
2021 21
2022 16
2023 22
2024 20
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Results by year

Filters applied: . Clear all
Page 1
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry").
Erton ZB, Leaf RK, de Andrade D, Clarke A, Tektonidou MG, Pengo V, Sciascia S, Pardos-Gea J, Kello N, Paredes-Ruiz D, Lopez-Pedrera C, Belmont HM, Fortin PR, Ramires de Jesús G, Atsumi T, Zhang Z, Efthymiou M, Branch DW, Pazzola G, Andreoli L, Duarte-García A, Rodriguez-Almaraz E, Petri M, Cervera R, Artim-Esen B, Quintana R, Shi H, Zuo Y, Willis R, Barber MRW, Skeith L, Radin M, Meroni P, Bertolaccini ML, Cohen H, Roubey R, Erkan D. Erton ZB, et al. Among authors: pengo v. Lupus. 2025 Apr 3:9612033251332258. doi: 10.1177/09612033251332258. Online ahead of print. Lupus. 2025. PMID: 40180601
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository.
Ahmadzadeh Y, Magder LS, de Andrade DCO, Paredes-Ruiz D, Tektonidou MG, Pengo V, Sciascia S, Andreoli L, Signorelli F, Fortin PR, Efthymiou M, Belmont HM, Barilaro G, Clarke AE, Atsumi T, López-Pedrera C, Knight JS, Branch DW, Willis R, Kello N, Zhang Z, Almaraz ER, Artim-Esen B, Pardos-Gea J, Pons-Estel G, Pazzola G, Shi H, Duarte-García A, Thaler J, Barber MRW, Skeith L, Radin M, Meroni PL, Roubey R, Bertolaccini ML, Cohen H, Petri M, Erkan D. Ahmadzadeh Y, et al. Among authors: pengo v. Arthritis Care Res (Hoboken). 2025 Feb 2. doi: 10.1002/acr.25503. Online ahead of print. Arthritis Care Res (Hoboken). 2025. PMID: 39895040
Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome.
De Sio V, Gragnano F, Capolongo A, Guarnaccia N, Maddaluna P, Acerbo V, Galli M, Berteotti M, Sperlongano S, Cesaro A, Moscarella E, Pelliccia F, Patti G, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pengo V, Gresele P, Marcucci R, Calabrò P. De Sio V, et al. Among authors: pengo v. Int J Cardiol. 2025 Mar 15;423:133028. doi: 10.1016/j.ijcard.2025.133028. Epub 2025 Jan 29. Int J Cardiol. 2025. PMID: 39890028 Free article.
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry.
Aiello A, Sarti L, Sandri G, Poli D, Sivera P, Barcellona D, Prisco D, Pizzini AM, Vercillo G, Antonucci E, Palareti G, Pengo V; Start2 Antiphospholipid Registry collaborators. Aiello A, et al. Among authors: pengo v. Int J Lab Hematol. 2025 Apr;47(2):313-317. doi: 10.1111/ijlh.14416. Epub 2024 Dec 11. Int J Lab Hematol. 2025. PMID: 39660556
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Devreese KMJ, Bertolaccini ML, Branch DW, de Laat B, Erkan D, Favaloro EJ, Pengo V, Ortel TL, Wahl D, Cohen H. Devreese KMJ, et al. Among authors: pengo v. J Thromb Haemost. 2025 Feb;23(2):731-744. doi: 10.1016/j.jtha.2024.10.022. Epub 2024 Nov 5. J Thromb Haemost. 2025. PMID: 39510414 Review.
Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study.
Palareti G, Legnani C, Testa S, Paoletti O, Cini M, Antonucci E, Pengo V, Poli D, Ageno W, Prandoni P, Prisco D, Tosetto A; MAS Working Group. Palareti G, et al. Among authors: pengo v. Curr Probl Cardiol. 2025 Jan;50(1):102913. doi: 10.1016/j.cpcardiol.2024.102913. Epub 2024 Oct 30. Curr Probl Cardiol. 2025. PMID: 39481583
284 results